Substance P (SP) and neurotensin (NT) are neuropeptides isolated in the periphery and in
the central nervous system. They are involved in various regulatory processes in the …

Central nervous system adverse effects are commonly reported with pregabalin (PGB). On
the other hand, movement disorders (MDs) associated with this drug were rarely described …

Substance P (SP) has been implicated in learning and memory processes. This peptide
facilitated learning when injected peripherally or directly into the ventral pallidum. SP has …

The globus pallidus in the basal ganglia plays an important role in movement regulation.
Neuropeptides and endocannabinoids are neuronal signalling molecules that influence the …

Previous studies have suggested that the neurokinin-1 receptor (NK-1R) expressing
neurons in the globus pallidus (GP) receive substance P (SP), presumably released by axon …

Background: Pregabalin (PGB) is an L-type, voltage-dependent, calcium-channel blocker,
useful for the treatment of neuropathy pain and some forms of seizures. We report the case …

Drug-induced parkinsonism is the second common movement disorder after Parkinson's
disease. It occurs due to the use of not only neuroleptics but also some other medications as …

The undecapeptide substance P has been demonstrated to modulate neuronal activity in a
number of brain regions by acting on neurokinin-1 receptors. Anatomical studies revealed a …

Substance P is an important neurotransmitter or neuromodulator in central nervous system.
Morphological studies have revealed the existence of substance P and its high affinity …

The lateral posterior nucleus (LP) receives inputs from both neocortex and superior
colliculus (SC), and is involved with integration and processing of higher‐level visual …